Eurosurv. Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023

[tetano]

• Lara M Jeworowski[SUP]1,*[/SUP] , Barbara Mühlemann[SUP]1,2,*[/SUP] , Felix Walper[SUP]1[/SUP] , Marie L Schmidt[SUP]1[/SUP] , Jenny Jansen[SUP]1[/SUP] , Andi Krumbholz[SUP]3,4[/SUP] , Etienne Simon-Lorière[SUP]5,6[/SUP] , Terry C Jones[SUP]1,2,7[/SUP] , Victor M Corman[SUP]1,2,8,**[/SUP] , Christian Drosten[SUP]1,2,**[/SUP]

Variant BA.2.86 and its descendant, JN.1, of SARS-CoV-2 are rising in incidence across Europe and globally. We isolated recent JN.1, BA.2.86, EG.5, XBB.1.5 and earlier variants. We tested live virus neutralisation of sera taken in September 2023 from vaccinated and exposed healthy persons (n = 39). We found clear neutralisation escape against recent variants but no specific pronounced escape for BA.2.86 or JN.1. Neutralisation escape corresponds to recent variant predominance but may not be causative of the recent upsurge in JN.1 incidence.

https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2024.29.2.2300740#html_fulltext
​